Medical Search

Medical News from FDA US Food & Drug

FDA warns of potential contamination in multiple brands of drugs, dietary supplements

August 11, 2017, 12:34 pm by FDA US Food & Drug

The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.


Featured Medical Stories

Newest Fitbits

Have you seen the NEW FITBIT??

Fitbit is now a health tracker and fasion statement. See all the new beautiful models here >> See the HOTTEST new Fitbits!

See the HOT Fitbit Blaze Now Compare All Fitbit Products Google Fitbit
Sense Sleep Tracker

Awaken Your Sleeping Beauty With This Sleep Tracker

Sleep is the new hot topic and from what science tells us, it is the holy grail of health. If you can track it, you can optimize it. If you can optimize it, you can benefit from it. This hot new sleep tracker by Hello is the perfect sleep tracker for the perfect price. There is beauty in health, and it needs to be awakened. But before that, let's get the best sleep of our lives. Learn more here: Sense Sleep Tracker on Amazon

Sleep Tracker on Amazon Sleep Tracker Reviews Google Sleep Trackers

More medical news from FDA US Food & Drug

Statement from Stephen Ostroff M.D., Deputy Commissioner for Foods and Veterinary Medicine, on National Toxicology Program draft report on Bisphenol A
FDA US Food & Drug : February 23, 2018, 11:42 am
FDA provides update on Clarity-BPA

FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid
FDA US Food & Drug : February 21, 2018, 8:20 am
FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid

FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
FDA US Food & Drug : February 16, 2018, 1:48 am
FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing

FDA expands treatment window for use of clot retrieval devices in certain stroke patients
FDA US Food & Drug : February 15, 2018, 9:20 am
FDA expands treatment window for use of clot retrieval devices in certain stroke patient

Statement from FDA Commissioner Scott Gottlieb, M.D. on advancing the development of novel treatments for neurological conditions; part of broader effort on modernizing FDA’s new drug review programs
FDA US Food & Drug : February 15, 2018, 6:31 am
FDA’s 5 guidance documents provide details for drug development for neurological conditions such as ALS and Alzheimer’s disease